Summary
This 8-K filing from Anthem, Inc. (now Elevance Health) on April 25, 2018, primarily serves to furnish a press release detailing the company's financial results for the first quarter ended March 31, 2018. While the filing itself doesn't contain the detailed financial figures, it directs investors to the attached press release (Exhibit 99.1) for this crucial information. Investors should refer to that exhibit for comprehensive insights into the company's performance during the quarter, including revenue, earnings, and any forward-looking guidance provided by management. The filing also includes standard legal disclosures, such as the classification of Anthem as an "emerging growth company" and the disclaimer that information furnished under Item 2.02 is not deemed "filed" for certain regulatory purposes. Crucially, the document contains extensive "forward-looking statements" that outline potential risks and uncertainties the company faces, including regulatory changes (like the ACA), healthcare cost trends, competitive pressures, and ongoing litigation. Investors are strongly advised to review these risk factors to understand the potential impact on future financial results.
Key Highlights
- 1Anthem, Inc. (now Elevance Health) filed an 8-K on April 25, 2018, to report its Q1 2018 financial results.
- 2The detailed financial results are provided in a press release furnished as Exhibit 99.1 to this filing.
- 3Investors should consult Exhibit 99.1 for specific Q1 2018 earnings, revenue, and operational performance data.
- 4The filing notes Anthem's status as an emerging growth company.
- 5Information furnished in this report is not considered 'filed' for Section 18 of the Securities Exchange Act purposes.
- 6The report includes a comprehensive list of forward-looking statements and associated risks and uncertainties.